Important documents

Important information

Nothing in this website or on the Blossom iOS or Android app should be construed as being personal financial advice. It is general nature only and has not taken into account your particular circumstances, objectives, financial situation or needs. You should consider whether the information, strategies and investments are appropriate and suitable for you or seek personal advice from a licensed financial planner before making an investment decision.

An investment in the Fund is subject to investment risk (see below under “Blossom Fund and PDS”). The target rate of annual return from investments retained in the Fund is not guaranteed and no assurance is given that the target rate will be achieved for any time the investment is held in the Fund. Distributions from the Fund to investors may be lower than targeted and may vary. Past performance of the Fund is not a reliable indicator of future performance. No performance is forecast.

Blossom Fund and PDS

Gleneagle Asset Management Limited ABN 29 103 162 278 AFSL 226199 is the responsible entity of the Blossom Fund ARSN 645 889 998 (Fund). BlossomApp Pty Ltd ABN 74 644 216 151 is Corporate authorised Representative No. 001284228 of Gleneagle Asset Management Limited.

It is important for you to obtain and consider the Product Disclosure Statement (PDS) for the Fund, along with the Target Market Determination, before deciding whether to invest, or to continue to invest, in the Fund. The PDS, TMD and applications to invest are only available online (www.blossomapp.com) or through the Blossom iOS or Android app.

An investment in the Fund through holding an account is not a bank account deposit and is subject to investment risk, including the loss of capital invested. No assurance is given as to distributions or their rate when investments are withdrawn or repayment of moneys invested. Withdrawal rights are subject to liquidity and may be delayed or suspended (see the PDS). Other significant features and risks are disclosed in the PDS.